Tolazamide
Brand names,
Tolazamide
Analogs
Tolazamide
Brand Names Mixture
Tolazamide
Chemical_Formula
C14H21N3O3S
Tolazamide
RX_link
http://www.rxlist.com/cgi/generic/tolinase.htm
Tolazamide
fda sheet
Tolazamide
msds (material safety sheet)
Tolazamide
Synthesis Reference
No information avaliable
Tolazamide
Molecular Weight
311.401 g/mol
Tolazamide
Melting Point
170-173 oC
Tolazamide
H2O Solubility
Solubility at pH 6.0 (mean urinary pH) is 27.8 mg/100 mL
Tolazamide
State
Solid
Tolazamide
LogP
2.674
Tolazamide
Dosage Forms
Tablets (100 mg, 250 mg or 500 mg)
Tolazamide
Indication
For use as an adjunct to diet to lower the blood glucose in patients with non-insulin dependent diabetes mellitus (Type II) whose hyperglycemia cannot be satisfactorily controlled by diet alone.
Tolazamide
Pharmacology
Tolazamide is an oral blood glucose lowering drug of the sulfonylurea class. Tolazamide appears to lower the blood glucose acutely by stimulating the release of insulin from the pancreas, an effect dependent upon functioning beta cells in the pancreatic islets. The mechanism by which tolazamide lowers blood glucose during long-term administration has not been clearly established. With chronic administration in Type II diabetic patients, the blood glucose lowering effect persists despite a gradual decline in the insulin secretory response to the drug. Extrapancreatic effects may be involved in the mechanism of action of oral sulfonylurea hypoglycemic drugs. Some patients who are initially responsive to oral hypoglycemic drugs, including tolazamide, may become unresponsive or poorly responsive over time. Alternatively, tolazamide may be effective in some patients who have become unresponsive to one or more other sulfonylurea drugs. In addition to its blood glucose lowering actions, tolazamide produces a mild diuresis by enhancement of renal free water clearance.
Tolazamide
Absorption
Rapidly and well absorbed from the gastrointestinal tract.
Tolazamide
side effects and Toxicity
Overdosage of sulfonylureas can produce hypoglycemia. Severe hypoglycemic reactions with coma, seizure, or other neurological impairment occur infrequently, but constitute medical emergencies requiring immediate hospitalization.
Tolazamide
Patient Information
Tolazamide
Organisms Affected
Humans and other mammals